Jagsonpal Pharmaceuticals Limited has informed the Exchange about Link of Recording
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagsonpal Pharmaceuticals has shared the audio recording link of its Q4 FY25 earnings conference call held on May 7, 2025 at 4:00 PM. The recording covers the discussion of Q4 FY25 financial results and is now available on the company's website under the investor relations section. This is a routine compliance filing under SEBI's Listing Obligations and Disclosure Requirements Regulations. The company had earlier intimated the exchange about the conference call on April 30, 2025.
No direct impact on stock price. Investors who want to hear management's commentary on Q4 FY25 results can listen to the recording for additional context beyond the published financial numbers.